Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Platform-based, Instrument-based), By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Application, By End-use, By Region, And Segment Forecasts, 2023

The global breast cancer diagnostics market size is expected to reach USD 7.7 billion by 2030. The market is expected to expand at a CAGR of 7.4% from 2023 to 2030. The growth is largely attributable to the increasing geriatric population exposed to the risk of breast cancer and early detection coupled with increasing awareness about breast cancer.

The introduction of 3D mammography or digital breast tomosynthesis, which is more accurate than 2D mammography, supports market growth. This advanced technology can detect 40.0% more cancers than 2D mammograms and reduce patient recalls. Rapid technological advancements are a major factor expected to drive the market over the coming years.

Companies are adopting strategies that allow them to use their resources to aid in the development of new products, as well as enhance their supply chain. In November 2019, Exact Sciences Corporation announced the acquisition of Genomic Health, which was expected to help enhance the company’s market position and offerings by acquiring its product portfolio. In January 2021, Hologic Inc. announced that it has agreed to acquire Biotheranostics for approximately US$ 230 million. Biotheranostics is a commercial-stage molecular diagnostics provider for breast and metastatic cancers.

The increasing launch of predictive and companion diagnostic tests for breast cancer is expected to boost the market growth. Recent launches in the segment include BRACAnalysis CDx by Myriad Genetics, which received FDA approval in 2018 as breast cancer companion diagnostics. In May 2019, QIAGEN introduced therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for Novartis proprietary PIQRAY in guiding treatment decisions from tissue and liquid biopsy.

In January 2019, the Fujifilm Holdings Corporation introduced its Tomosynthesis Biopsy option for ASPIRE Cristalle mammography system. This technique was expected to enable physicians to detect breast cancers more efficiently compared to others by providing an enhanced 3D image and a digital mammogram.

However, there are specific risk factors associated with these imaging procedures. They involve administering high doses of fluorescent and barium contrast agents, as well as radiation exposure in the case of imaging and endoscopic procedures, which can cause several adverse effects such as nausea or diarrhea. The risks of ionizing radiation exposure associated with the use of CT, MRI, and X-rays, as well as the use of radioactive tracer injections in PET can limit the adoption of such screening procedures. Therefore, factors such as adverse effects of imaging act as a challenge for the companies in this market.

Breast Cancer Diagnostics Market Report Highlights

The imaging segment held the largest revenue share in 2022 and the blood tests segment is expected to grow at the fastest rate
By product, the instrument-based products segment accounted for the largest revenue share in 2022 due to government initiatives such as mandatory screening in developed countries such as the U.S., Canada, and the U.K. for women above 45 years of age, increasing the overall testing and screening of breast cancer
The platform-based products segment is expected to witness the fastest growth over the forecast period. These tests are mostly used for assessing the efficacy of chemotherapy and targeted therapy in women
By application, the diagnostic and predictive segment dominated the market in 2022 and the prognostic segment is expected to witness the fastest CAGR over the forecast period due to increasing collaborations and efforts for advancements in diagnostics
The hospitals and clinics segment dominated the market in 2022
The medical labs and diagnostics centers segment is expected to witness the fastest CAGR over the forecast period due to an increase in platform-based testing such as NGS, and PCR

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Product
1.1.3. Application
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Product outlook
2.2.3. Application outlook
2.2.4. End-use outlook
2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Breast Cancer Diagnostics Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Breast Cancer Diagnostics Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape

Chapter 4. Breast Cancer Diagnostics: Type Estimates & Trend Analysis

4.1. Breast Cancer Diagnostics Market, Key Takeaways
4.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Imaging
4.3.1. Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Biopsy
4.4.1. Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Genomic Tests
4.5.1. Genomic tests market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Blood Tests
4.6.1. Blood tests market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Breast Cancer Diagnostics: Product Estimates & Trend Analysis

5.1. Breast Cancer Diagnostics Market, Key Takeaways
5.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Platform-based Products
5.3.1. Platform-based products market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.1.1. Next-generation sequencing
5.3.1.1.1. Next-generation sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.1.2. Microarrays
5.3.1.2.1. Microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.1.3. PCR
5.3.1.3.1. PCR market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.1.4. Others
5.3.1.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Instruments-based Products
5.4.1. Instruments-based products market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.1.1. Imaging
5.4.1.1.1. Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.1.2. Biopsy
5.4.1.2.1. Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Breast Cancer Diagnostics: Application Estimates & Trend Analysis

6.1. Breast Cancer Diagnostics Market, Key Takeaways
6.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Screening
6.3.1. Screening market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Diagnostic and Predictive
6.4.1. Diagnostic and predictive market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Prognostic
6.5.1. Prognostic market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Research
6.6.1. Research market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Breast Cancer Diagnostics: End-use Estimates & Trend Analysis

7.1. Breast Cancer Diagnostics Market, Key Takeaways
7.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals & Clinics
7.3.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Diagnostic Centers and Medical Laboratories
7.4.1. Diagnostic centers and medical laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Others
7.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Breast Cancer Diagnostics Market: Regional Estimates & Trend Analysis

8.1. Regional Outlook
8.2. Breast Cancer Diagnostics Market by Region: Key Takeaway
8.3. North America
8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.6. Sweden
8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.7. Norway
8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.8. Denmark
8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. Saudi Arabia
8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.2. South Africa
8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Hologic Inc.
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product Benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Genomic Health (Exact Sciences Corporation)
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. BD
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Danaher
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Koninklijke Philips N.V.
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. QIAGEN
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Thermo Fisher Scientific Inc.
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Myriad Genetics, Inc.
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Argon Medical Devices, Inc.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. F. Hoffmann-La Roche Ltd.
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 North America breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 3 North America breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 4 North America breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 5 North America breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 6 North America breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 7 U.S. breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 8 U.S. breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 9 U.S. breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 10 U.S. breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 11 Canada breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 12 Canada breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 13 Canada breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 14 Canada breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 16 Europe breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 17 Europe breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 18 Europe breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 19 Europe breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 20 Germany breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 21 Germany breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 22 Germany breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 23 Germany breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 24 UK breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 25 UK breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 26 UK breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 27 UK breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 28 France breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 29 France breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 30 France breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 31 France breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 32 Italy breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 33 Italy breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 34 Italy breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 35 Italy breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 36 Spain breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 37 Spain breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 38 Spain breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 39 Spain breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 40 Sweden breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 41 Sweden breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 42 Sweden breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 44 Norway breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 45 Norway breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 46 Norway breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 47 Norway breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 48 Denmark breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 49 Denmark breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 50 Denmark breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 51 Denmark breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 52 Asia Pacific breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 53 Asia Pacific breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 54 Asia Pacific breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 55 Asia Pacific breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 56 Asia Pacific breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 57 Japan breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 58 Japan breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 59 Japan breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 60 Japan breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 61 China breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 62 China breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 63 China breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 64 China breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 65 India breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 66 India breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 67 India breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 68 India breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 69 Australia breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 70 Australia breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 71 Australia breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 72 Australia breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 73 Thailand breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 74 Thailand breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 75 Thailand breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 76 Thailand breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 77 South Korea breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 78 South Korea breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 79 South Korea breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 80 South Korea breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 81 Latin America breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 82 Latin America breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 83 Latin America breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 84 Latin America breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 85 Latin America breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 86 Brazil breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 87 Brazil breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 88 Brazil breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 89 Brazil breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 90 Mexico breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 91 Mexico breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 92 Mexico breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 93 Mexico breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 94 Argentina breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 95 Argentina breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 96 Argentina breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 97 Argentina breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 103 Saudi Arabia breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 104 Saudi Arabia breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 105 Saudi Arabia breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 107 South Africa breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 108 South Africa breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 109 South Africa breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 110 South Africa breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 111 UAE breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 112 UAE breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 113 UAE breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 114 UAE breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 115 Kuwait breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 116 Kuwait breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 117 Kuwait breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 118 Kuwait breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Breast cancer diagnostics: Market outlook
Fig. 9 Breast cancer diagnostics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Breast cancer diagnostics market driver impact
Fig. 15 Breast cancer diagnostics market restraint impact
Fig. 16 Breast cancer diagnostics strategic initiatives analysis
Fig. 17 Breast cancer diagnostics market: Type movement analysis
Fig. 18 Breast cancer diagnostics market: Type outlook and key takeaways
Fig. 19 Imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Genomic tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Blood tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Breast cancer diagnostics market: Product movement analysis
Fig. 25 Breast cancer diagnostics market: Product outlook and key takeaways
Fig. 26 Platform based products market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Next-generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Instruments-based products market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Breast cancer diagnostics market: Application movement analysis
Fig. 34 Breast cancer diagnostics market: Application outlook and key takeaways
Fig. 35 Screening market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Diagnostic and predictive market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Prognostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Research market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Breast cancer diagnostics market: End-use movement analysis
Fig. 40 Breast cancer diagnostics market: End-use outlook and key takeaways
Fig. 41 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Diagnostic centers and medical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Global breast cancer diagnostics market: Regional movement analysis
Fig. 45 Global breast cancer diagnostics market: Regional outlook and key takeaways
Fig. 46 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

Hologic Inc.
Genomic Health (Exact Sciences Corporation)
BD
Danaher
Koninklijke Philips N.V.
QIAGEN
Thermo Fisher Scientific Inc.
Myriad Genetics, Inc.
Argon Medical Devices, Inc.
F. Hoffmann-La Roche Ltd

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	190
Published	September 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 4.3 Billion
Forecasted Market Value ( USD ) by 2030	$ 7.7 Billion
Compound Annual Growth Rate	7.4%
Regions Covered	Global
No. of Companies Mentioned	10

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5817EUR$5,950USD£4,859GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6794EUR$6,950USD£5,675GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8750EUR$8,950USD£7,308GBP

Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Platform-based, Instrument-based), By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Breast Cancer Diagnostics Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Breast Cancer Diagnostics Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Type (IVD, LDT), Application (Breast Cancer, Lung Cancer), End-use, Test Type, and Segment Forecasts, 2024-2030

Breast Cancer Diagnostics Market by Technique, Cancer Type, Component, Diagnostic Type, End-User - Global Forecast 2025-2030

Next-Generation Breast Cancer Diagnostic & Screening Market by Product, Diagnostic Technology, Screening Technology, Application, End User - Global Forecast 2025-2030

Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report by Technology, End-use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), Region, and Segment Forecasts, 2023-2030

Breast Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030